Changes to DNA, known as mutations, can increase the likelihood of developing cancer. Specifically, people with mutations in their BRCA 1 and 2 genes are substantially more likely to develop hereditary breast and ovarian cancers. But how do people know if they have these mutations?
Recipharm to change CEOs, spin out inhaler business
Recipharm CEO Marc Funk is stepping down at the beginning of next year, and a former Nestlé executive is set to take over as chief
November 23, 2023